BACKGROUND: Previous psychotherapy research has examined the therapeutic alliance and therapist adherence as correlates or predictors of symptom change. While some initial evidence suggests the alliance is associated with risk of dropout in cognitive behavioral treatment for depression, evidence of such relations has been limited to date. We examined the relation of these psychotherapy process variables and dropout in the context of cognitive therapy for depression when provided in combination with pharmacotherapy. METHODS: Patients were randomized to the CT plus pharmacotherapy condition of a clinical trial for chronic or recurrent depression. Consistent with the spirit of personalized medicine, patients were treated until they met remission and recovery criteria (or reached the maximum allowable time in the study). In a sample of 176 patients, we examined observer-rated alliance and therapist adherence in the first three CT sessions as potential predictors of treatment dropout. RESULTS: The therapeutic alliance and one facet of therapist adherence (i.e., Behavioral Methods/Homework) predicted reduced odds of dropout. Therapist use of Negotiating/Structuring predicted greater likelihood of dropout, but only when other variables were included in the model. LIMITATIONS: Process ratings were not available for concurrent pharmacotherapy sessions. A minority of patients did not have session recordings available. CONCLUSIONS: Results are consistent with the possibility that the therapeutic alliance and therapists' focus on homework and behavioral methods promote treatment retention in combined treatment for depression.
RCT Entities:
BACKGROUND: Previous psychotherapy research has examined the therapeutic alliance and therapist adherence as correlates or predictors of symptom change. While some initial evidence suggests the alliance is associated with risk of dropout in cognitive behavioral treatment for depression, evidence of such relations has been limited to date. We examined the relation of these psychotherapy process variables and dropout in the context of cognitive therapy for depression when provided in combination with pharmacotherapy. METHODS:Patients were randomized to the CT plus pharmacotherapy condition of a clinical trial for chronic or recurrent depression. Consistent with the spirit of personalized medicine, patients were treated until they met remission and recovery criteria (or reached the maximum allowable time in the study). In a sample of 176 patients, we examined observer-rated alliance and therapist adherence in the first three CT sessions as potential predictors of treatment dropout. RESULTS: The therapeutic alliance and one facet of therapist adherence (i.e., Behavioral Methods/Homework) predicted reduced odds of dropout. Therapist use of Negotiating/Structuring predicted greater likelihood of dropout, but only when other variables were included in the model. LIMITATIONS: Process ratings were not available for concurrent pharmacotherapy sessions. A minority of patients did not have session recordings available. CONCLUSIONS: Results are consistent with the possibility that the therapeutic alliance and therapists' focus on homework and behavioral methods promote treatment retention in combined treatment for depression.
Authors: Marna S Barrett; Wee-Jhong Chua; Paul Crits-Christoph; Mary Beth Gibbons; D Casiano; Don Thompson Journal: Psychotherapy (Chic) Date: 2008-06-01
Authors: Steven D Hollon; Robert J DeRubeis; Jan Fawcett; Jay D Amsterdam; Richard C Shelton; John Zajecka; Paula R Young; Robert Gallop Journal: JAMA Psychiatry Date: 2014-10 Impact factor: 21.596
Authors: D R Strunk; M O Stewart; S D Hollon; R J DeRubeis; J Fawcett; J D Amsterdam; R C Shelton Journal: Psychol Med Date: 2009-11-06 Impact factor: 7.723
Authors: John E Zeber; Karen J Coleman; Heidi Fischer; Tae K Yoon; Brian K Ahmedani; Arne Beck; Samuel Hubley; Zac E Imel; Rebecca C Rossom; Susan M Shortreed; Christine Stewart; Beth E Waitzfelder; Greg E Simon Journal: Depress Anxiety Date: 2017-11-02 Impact factor: 6.505
Authors: D A van Dijk; M L Deen; Th M van den Boogaard; H G Ruhé; J Spijker; F P M L Peeters Journal: Eur Arch Psychiatry Clin Neurosci Date: 2022-10-17 Impact factor: 5.760
Authors: Zarqa Ali; Kathryn Anderson; Andrei Chiriac; Anders Daniel Andersen; Ari Pall Isberg; Fernando Gesto Moreno; Aleksander Eiken; Simon Francis Thomsen; John Robert Zibert Journal: PLoS One Date: 2020-07-02 Impact factor: 3.240